Each pharmaceutical compound has its own characteristics and formulation challenges. InnoCore has many years of experience and case studies tailoring sustained release technologies to meet the requirements of a large variety of compounds.
InnoCore has patented technologies suitable for a variety of compounds. By entrapment in a polymer matrix, the API can be protected from degradation.
Robert Hof joined InnoCore as Chief Executive Officer in June 2023. Previous to joining InnoCore, Robert worked in various...
Read more
Rob Steendam, is Co-Founder and Chief Technology Officer at InnoCore. He holds an MSc degree in polymer chemistry and a PhD...
Read more
Bart-Jan joined InnoCore as Chief Operating Officer in February 2025 to lead pharmaceutical development projects and to lead the...
Read more
Martin Bakker, Chief Business Officer since 2015 (independent contractor). In the past, he worked for several companies in...
Read more
Dirk Jan van Drooge joined Innocore as Director Development in November 2023 to lead the Formulation and Process Development...
Read more
Director Operations since 2022 and Manager of the Analytical (as of 2012) and the Polymer R&D Department. Wilma is...
Read more
Johan Zuidema joined InnoCore in 2009, working in different roles in Technology Development, Process Development and since 2014...
Read more
Aiva Simaite has joined InnoCore as a Project Manager in 2022. She holds a PhD in Micro-/Nanofabrication and has extensive...
Read more
Thanh Nguyen is a Project Manager at InnoCore. Thanh joined InnoCore in 2014 and since then has developed his career in project...
Read more